Status:
RECRUITING
An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology
Lead Sponsor:
Erasmus Medical Center
Conditions:
Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
The I-FILE study is a prospective multicenter, multinational observational study where the feasibility of a patient-led registry using home monitoring in patients with pulmonary fibrosis will be evalu...
Detailed Description
Nowadays, identifying disease progression will have direct treatment implications in patients with fibrotic Interstitial lung diseases (F-ILDs). eHealth could be a possible solution for close monitori...
Eligibility Criteria
Inclusion
- Newly diagnosed patients with F-ILD according to the ATS/ERS criteria by a multidisciplinary ILD team :
- MDT diagnosis ≤ 6 months before inclusion
- Treatment for F-ILD ≤ than 1 month
Exclusion
- Not able to speak, read or write in the native language of the country where the patient is included
- Not able to comply to the study protocol, according to the judgement of the investigator and/or patient
- No access to internet
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04304898
Start Date
May 1 2020
End Date
July 1 2026
Last Update
March 20 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC
Rotterdam, South Holland, Netherlands, 3015 CE
2
Erasmus MC
Rotterdam, Netherlands